Credit: IMBA
Scientists have managed to grow perfect human blood vessels as organoids in a petri dish for the first time.
The breakthrough engineering technology, outlined in a new study published today in Nature,
dramatically advances research of vascular diseases like diabetes,
identifying a key pathway to potentially prevent changes to blood
vessels -- a major cause of death and morbidity among those with
diabetes.
An organoid is a three-dimensional structure grown from stem cells
that mimics an organ and can be used to study aspects of that organ in a
petri dish.
"Being able to build human blood vessels as organoids from stem cells
is a game changer," said the study's senior author Josef Penninger, the
Canada 150 Research Chair in Functional Genetics, director of the Life
Sciences Institute at UBC and founding director of the Institute for
Molecular Biotechnology of the Austrian Academy of Sciences (IMBA).
"Every single organ in our body is linked with the circulatory
system. This could potentially allow researchers to unravel the causes
and treatments for a variety of vascular diseases, from Alzheimer's
disease, cardiovascular diseases, wound healing problems, stroke, cancer
and, of course, diabetes."
Diabetes affects an estimated 420 million people worldwide. Many
diabetic symptoms are the result of changes in blood vessels that result
in impaired blood circulation and oxygen supply of tissues. Despite its
prevalence, very little is known about the vascular changes arising
from diabetes. This limitation has slowed the development of much-needed
treatment.
To tackle this problem, Penninger and his colleagues developed a
groundbreaking model: three-dimensional human blood vessel organoids
grown in a petri dish. These so-called "vascular organoids" can be
cultivated using stem cells in the lab, strikingly mimicking the
structure and function of real human blood vessels.
When researchers transplanted the blood vessel organoids into mice,
they found that they developed into perfectly functional human blood
vessels including arteries and capillaries. The discovery illustrates
that it is possible to not only engineer blood vessel organoids from
human stem cells in a dish, but also to grow a functional human vascular
system in another species.
"What is so exciting about our work is that we were successful in
making real human blood vessels out of stem cells," said Reiner Wimmer,
the study's first author and a postdoctoral research fellow at IMBA.
"Our organoids resemble human capillaries to a great extent, even on a
molecular level, and we can now use them to study blood vessel diseases
directly on human tissue."
One feature of diabetes is that blood vessels show an abnormal
thickening of the basement membrane. As a result, the delivery of oxygen
and nutrients to cells and tissues is strongly impaired, causing a
multitude of health problems, such as kidney failure, heart attacks,
strokes, blindness and peripheral artery disease, leading to
amputations.
The researchers then exposed the blood vessel organoids to a "diabetic" environment in a petri dish.
"Surprisingly, we could observe a massive expansion of the basement
membrane in the vascular organoids," said Wimmer. "This typical
thickening of the basement membrane is strikingly similar to the
vascular damage seen in diabetic patients."
The researchers then searched for chemical compounds that could block
thickening of the blood vessel walls. They found none of the current
anti-diabetic medications had any positive effects on these blood vessel
defects. However, they discovered that an inhibitor of ?-secretase, a
type of enzyme in the body, prevented the thickening of the blood vessel
walls, suggesting, at least in animal models, that blocking ?-secretase
could be helpful in treating diabetes.
The researchers say the findings could allow them to identify
underlying causes of vascular disease, and to potentially develop and
test new treatments for patients with diabetes.
Journal Reference:
- Reiner A. Wimmer, Alexandra Leopoldi, Martin Aichinger, Nikolaus Wick, Brigitte Hantusch, Maria Novatchkova, Jasmin Taubenschmid, Monika Hämmerle, Christopher Esk, Joshua A. Bagley, Dominik Lindenhofer, Guibin Chen, Manfred Boehm, Chukwuma A. Agu, Fengtang Yang, Beiyuan Fu, Johannes Zuber, Juergen A. Knoblich, Dontscho Kerjaschki & Josef M. Penninger. Human blood vessel organoids as a model of diabetic vasculopathy. Nature, 2019 DOI: 10.1038/s41586-018-0858-8
Courtesy: ScienceDaily
No comments:
Post a Comment